Alexis Borisy, Third Rock Ventures partner, discusses the fund’s biotech investment strategy on “Bloomberg Technology {iframe}https://www.bloomberg.com/news/videos/2019-05-13/how-venture-capital-is-investing-in-gene-therapy-video{/iframe}